moclobemide has been researched along with Addiction, Opioid in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Moclobemide is a specific and reversible monoamine oxidase-A (MAO-A) inhibitor." | 1.31 | Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report. ( Bailly, D; De Lenclave, MB; Vaiva, G, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vaiva, G | 1 |
| De Lenclave, MB | 1 |
| Bailly, D | 1 |
1 other study available for moclobemide and Addiction, Opioid
| Article | Year |
|---|---|
Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Diagnosis, Dual (Psychiatry); Humans; Male; Mo | 2002 |